T1	Participants 243 282	patients with moderate-to-severe asthma
T2	Participants 559 655	patients with moderate-to-severe asthma who were uncontrolled on existing corticosteroid therapy
T3	Participants 2227 2278	symptomatic patients with moderate-to-severe asthma
